Skip to content
Home
About us
Co-founders
Our Team
Scientific Advisors
Our Product Pipeline
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Scientific Advisors
Our Product Pipeline
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Collaboration on modelling of inherited retinal disorders with complex mutations and developing a high-throughput drug screening platform
Home
Collaboration
Collaboration on modelling of inherited retinal disorders with complex mutations and developing a high-throughput drug screening platform
Post Author:
eyetem@admin
Post navigation
Previous Post
Collaboration agreement for safety and efficacy studies using iPSC-derived Dopaminergic neuronal progenitors in rodent models of Parkinson’s Disease
Next Post
National Institute of Mental Health and Neurosciences (NIMHANS)
